1294 logo

Hantech Bio-Technology Co., Ltd. Stock Price

TPEX:1294 Community·NT$2.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

1294 Share Price Performance

NT$78.80
-22.94 (-22.55%)
NT$78.80
-22.94 (-22.55%)
Price NT$78.80

1294 Community Narratives

There are no narratives available yet.

Recent 1294 News & Updates

Hantech Bio-Technology Co., Ltd. Key Details

NT$720.6m

Revenue

NT$437.7m

Cost of Revenue

NT$283.0m

Gross Profit

NT$138.4m

Other Expenses

NT$144.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
4.81
Gross Margin
39.27%
Net Profit Margin
20.06%
Debt/Equity Ratio
14.8%

Hantech Bio-Technology Co., Ltd. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet second-rate dividend payer.

1 Risk
1 Reward

About 1294

Founded
2007
Employees
152
CEO
Yulin Li
WebsiteView website
www.htbios.com

Hantech Bio-Technology Co., Ltd. manufactures and sells health supplement products in Taiwan. It provides dietary supplements in gel, liquid, and powder forms under OEM or ODM partnerships. The company offers its dietary supplements in various packages, such as rectangle, curve, Z, round, wine bottle, and standing pouches. Hantech Bio-Technology Co., Ltd. was founded in 2007 and is headquartered in Yuanlin City, Taiwan.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Taiwanese Market Performance

  • 7 Days: 4.4%
  • 3 Months: 19.2%
  • 1 Year: 16.0%
  • Year to Date: 16.2%
Over the last 7 days, the market has risen 4.4%, driven by gains of 6.3% in the Information Technology sector. The market is up 16% over the last 12 months. As for the next few years, earnings are expected to grow by 18% per annum. Market details ›